FDA Inspection 671922 — Regenerative Biologics, Inc.

Regenerative Biologics, Inc. — FEI 3003567044

The FDA completed an inspection of Regenerative Biologics, Inc. on Jul 14, 2010 in Melbourne, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Jul 14, 2010
Fiscal Year
2010
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Melbourne, FL (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.